# Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

Study · id `cardio:ct-nct01252810` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01252810](<https://clinicaltrials.gov/study/NCT01252810>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01252810

Browse, organ or system: Heart; Kidneys  
Browse, condition area: Heart failure; Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.

## Technical summary

Registry record NCT01252810. Randomized; double masking; primary purpose diagnostic. Start 2010-11 (registry gives no type); primary completion 2012-12 (actual). Results posted on 2014-05-02.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose diagnostic
- Phase: Phase 2
- Enrolled: 284 participants (enrolled count; ClinicalTrials.gov record NCT01252810, source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01252810, source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)
- Primary completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01252810, source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)
- Completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01252810, source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)
- Results first posted: 2014-05-02 (ClinicalTrials.gov record NCT01252810, source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01252810, source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01252810-2018-08-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
- Condition: Chronic Renal Insufficiency
- Condition: Diabete Mellitus
- Condition: Congestive Heart Failure
- Intervention (Drug): GE-145
- Lead sponsor: GE Healthcare
- Lead sponsor class: INDUSTRY
- Collaborator: i3 Statprobe
- Collaborator class: INDUSTRY
- Collaborator: Medpace, Inc.
- Collaborator class: INDUSTRY
- Collaborator: Biomedical Systems
- Collaborator class: INDUSTRY
- Collaborator: Rules-Based Medicine, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: GE Healthcare (`cardio:org-ge-healthcare`)
- Registry lists this organization as a collaborator: Medpace, Inc. (`cardio:org-medpace-inc`)

## Provenance

Content hash: f48bfd7e3db3e335a6c41bdb69202baf8a14bca6e3e5667e254eb115901c67b8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
